Humacyte, Inc. — Director's Dealing 2021

Nov 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Humacyte, Inc. (HUMA)
CIK: 0001818382
Period of Report: 2021-11-22

Reporting Person: Constantino Michael T. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-22	Common Stock	P	200	$10.83	Acquired	200	Direct
2021-11-22	Common Stock	P	2300	$10.7912	Acquired	2500	Direct